Autism: Is This a Vascular Disease and Would Therapeutic Angiogenesis Be a Potential Treatment? LAS VEGAS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Dr. Jack Jacobs, Chief Science Officer of Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), will be presenting at the online AutismOne...

Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure? LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Webinar broadcast on its potential breakthrough therapy to...

Zhittya Genesis Medicine Announces a Potential Major Medical Breakthrough for the Treatment of Parkinson’s Disease LAS VEGAS, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announces that it will initiate clinical trials to test a medical hypothesis that has been...

COVID-19 Lung Damage: Potential Breakthrough Drug Treatment Disclosed by Zhittya Genesis Medicine in Their Newly Released White Paper LAS VEGAS, June 17, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company)(“Zhittya” or the “Company”), announced that its latest White Paper, which details results on its...

Zhittya Genesis Medicine Releases Latest White Paper Highlighting its Potential Breakthrough Drug Treatment for Chronic Depression LAS VEGAS, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), announced that its latest White Paper, which details results on its...